CD4 and endocarditis: Thus, a vaccine that aims to protect against localised invasive S. aureus infections in the heart (i.e., endocarditis) bone (i.e., osteomyelitis), or lung (i.e., pneumonia) should aim to boost bacterium specific CD4+ Th1 polarised Trm in these tissue compartments.